(Q40607097)

22 September 2017

Description and predictors of direct and indirect costs of pain reported by cancer patients (English)

1 reference

22 September 2017

Barry V Fortner

1

1 reference

22 September 2017

Gail Demarco

2

1 reference

22 September 2017

Gordon Irving

3

1 reference

22 September 2017

Jeri Ashley

4

1 reference

22 September 2017

Ginny Keppler

5

1 reference

22 September 2017

Jana Chavez

6

1 reference

22 September 2017

Jana Munk

7

1 reference

22 September 2017

1 January 2003

1 reference

Journal of Pain and Symptom Management

22 September 2017

1 reference

22 September 2017

25

1 reference

22 September 2017

1

1 reference

22 September 2017

9-18

1 reference

Cancer pain. Epidemiology and syndromes

22 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900597-3

7 January 2021

The impact of pain on the patient with cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900597-3

7 January 2021

The multidimensional nature of cancer-related pain

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900597-3

7 January 2021

The prevalence and severity of pain in cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900597-3

7 January 2021

The prevalence of psychiatric disorders among cancer patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900597-3

7 January 2021

Pain in ovarian cancer patients. Prevalence, characteristics, and associated symptoms

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900597-3

7 January 2021

Breakthrough pain: characteristics and impact in patients with cancer pain.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900597-3

7 January 2021

Economics of unrelieved cancer pain

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900597-3

7 January 2021

The distinction between cost and charges

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900597-3

7 January 2021

The national economic burden of cancer: an update

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900597-3

7 January 2021

Costs of care associated with non-small-cell lung cancer in a commercially insured cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900597-3

7 January 2021

Routes of opioid analgesic therapy in the management of cancer pain

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900597-3

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900597-3

7 January 2021

Cost analysis of two implantable narcotic delivery systems

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900597-3

7 January 2021

Unmet analgesic needs in cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900597-3

7 January 2021

The cost of cancer home care to families

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900597-3

7 January 2021

Development of the Wisconsin Brief Pain Questionnaire to assess pain in cancer and other diseases

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900597-3

7 January 2021

Distribution of emergency department costs

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900597-3

7 January 2021

The costs of visits to emergency departments

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900597-3

7 January 2021

A cost analysis of a tele-oncology practice

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900597-3

7 January 2021

Breakthrough pain: definition, prevalence and characteristics

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900597-3

7 January 2021

When is cancer pain mild, moderate or severe? Grading pain severity by its interference with function.

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900597-3

7 January 2021

Why are cancer patients using non-proven complementary therapies? A cross-sectional multicentre study in Norway

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900597-3

7 January 2021

The use of unproven methods of treatment by cancer patients. Frequency, expectations and cost

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900597-3

7 January 2021

Use of alternative medicine--a marker for distress?

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900597-3

7 January 2021

Hospital readmissions as a measure of quality of health care: advantages and limitations

1 reference

https://api.crossref.org/works/10.1016%2FS0885-3924%2802%2900597-3

7 January 2021

10.1016/S0885-3924(02)00597-3

Identifiers

DOI

1 reference

22 September 2017

1 reference